Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel in Biochemically Relapsed Prostate Cancer
NCT00482274Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- May 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started May 2007; status: terminated.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00482274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482274.